Development of ONCR-148, a miR-attenuated oncolytic HSV-1 designed to potently activate antitumor T cell response
Agnieszka Denslow,Brian B. Haines,Michael S. Ball,Jacqueline Gursha,Daniel Wambua,Cecilia Kwong,Lingxin Kong,Allison Colthart,Prajna Behera,Peter Grzesik,Jennifer Lee,Terry Farkaly,Caitlin Goshert,Edward M. Kennedy,Lorena Lerner,Christophe Queva CANCER RESEARCH（2019）
AI 理解论文
溯源树
样例
